At-A-Glance: Opioid & Health Indicator Database
Long-Acting Agents in Development for HIV Treatment and Prevention
Key Populations, Size Estimates,and Plans in COP22
Violence Crisis Services During Lockdown: An Assessment of Service Availability During COVID-19 Lockdown in South Africa
Issue Brief: The Expanded Mexico City Policy: Implications for the Global Fund
New HIV Testing Strategies in PEPFAR COP19: Rollout and Human Rights Concerns
Expanding Access to Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults: Models for Addressing Consent, Confidentiality, and Payment Barriers
Issue Brief: Title X, the Domestic Gag Rule, and the HIV Response
The Effect of the Expanded Mexico City Policy on HIV/AIDS Programming: Evidence from the PEPFAR Implementing Partners Survey
Impact of Mexico City Policy on PEPFAR
The Case for Supervised Consumption Services
Preventing HIV and Hepatitis C Among People Who Inject Drugs: Public Funding for Syringe Services Programs Makes the Difference
A Neglected Population: Transgender Inclusion in National HIV Plans
A Global Response to HIV Requires the Global Fund
How the Global Fund Improves PEPFAR Investments
Lives on the Line: The Human Impact of Proposed Cuts to Global HIV Funding
Ending the HIV Epidemic Database
How Expanded Mexico City Policy Is Disrupting Global HIV Programs
Getting to Services:Far, Far Away
When Size Matters: How Social Media Can Help Determine Key Population Size
Context Matters: Ending the HIV Epidemic Among Black Communities
PEPFAR in the Age of COVID-19: The Human Impact of the Unmet Gap and the Need for Supplemental Funding
Blinded by Our Own Data—Recency Testing in PREPFAR
How Cures Can Fail
Context Matters: Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic
Toward an Effective Strategy to Combat HIV, Hepatitis C and the Opioid Epidemic: Recommendations for Policy Makers
Data Watch: Data Accessibility from Global Funders of HIV, TB, and Malaria Programming
Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Overview
Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: From Laboratory to Marketplace
Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Defining the Intended Market
Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Assessing the Payer Landscape
